Abstract:Camptothecin (CPT) is a potent anticancer agent for the treatment of colorectal cancer; however, it exhibits some limitations, including poor solubility, low stability, and low bioavailability via oral administration, which restrict its usability in clinical treatments. In addition, overproduction of reactive oxygen species (ROS) during chemotherapy induces drug resistance and severe intestinal side effects. In this study, silica-installed ROS scavenging nanoparticles (siRNP) with 50-60 nm in diameter were employed to overcome the aforementioned drawbacks of CPT. The solubility of CPT was significantly improved by incorporating it into the core of the nanoparticle, forming CPT-loaded siRNP (CPT@siRNP). The anticancer activity of CPT@siRNP against colorectal cancer cells (C-26) in vitro was significantly improved as compared to free CPT through higher efficiency of intracellular internalization and induction of apoptosis. Owing to its antioxidant properties, CPT@siRNP reduced cytotoxicity to normal endothelial cells, which was in sharp contrast to the high toxicity of free CPT. Oral administration of CPT and CPT@siRNP to the C-26 tumor-bearing mice exhibited antitumor activity, accompanied by effective suppression of tumor growth. Although CPT treatment suppressed tumor progression, it caused severe side effects, including intestinal damage and significant bodyweight loss. Interestingly, such noticeable side effects were not observed in the mice treated with CPT@siRNP, and the effect of tumor growth inhibition tended to be similar to or higher than that of CPT treatment. The results obtained in this study indicate that CPT@siRNP is a potential therapeutic nanomedicine for the treatment of colon cancer.Statement of significance Here we employed silica-containing antioxidant nanoparticle (siRNP) as promising oral delivery nanocarrier of campothecin (CPT) to treat colon cancer. The design of siRNP via covalent conjugation of antioxidant nitroxide radicals and the silanol groups in the polymer backbone contributes to a significant increase in the absorption of hydrophobic drug molecules inside the core and enhances the stability of nanoparticles in the gastrointestinal environment for oral drug delivery. CPT-loaded siRNP (CPT@siRNP) significantly improved solubility of CPT. As compared to free CTP, the CPT@siRNP treatment showed a significantly higher toxicity to colon cancer cell, inhibition of cancer cell migration, and induction of apopo-tosis. With the antioxidant feature, siRNP also significantly suppressed the intestinal side effects caused by CPT treatment in tumor-bearing mouse model.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Oral Delivery of Camptothecin Using Cyclodextrin/poly(anhydride) Nanoparticles

Camptothecin–Polysaccharide Co-assembly and Its Controlled Release

Nanomicelle Based Peroral Delivery System for Enhanced Absorption and Sustained Release of 10-Hydrocamptothecin

Linear-like polypeptide-based micelle with pH-sensitive detachable PEG to deliver dimeric camptothecin for cancer therapy

In Situ Encapsulation of Camptothecin by Self-Assembly of Poly(acrylic acid)-b-Poly(N-Isopropylacrylamide) and Chitosan for Controlled Drug Delivery

CPT Loaded Nanoparticles Based on Beta-Cyclodextrin-grafted Poly(ethylene Glycol)/poly (L-Glutamic Acid) Diblock Copolymer and Their Inclusion Complexes with CPT

Poly(Omega-Pentadecalactone-Co-Butylene-Co-Succinate) Nanoparticles As Biodegradable Carriers for Camptothecin Delivery

Preparation of camptothecin micelles self-assembled from disodium glycyrrhizin and tannic acid with enhanced antitumor activity

Preparation, Characterization and in Vivo Antitumor Evaluation of a Micellar Formulation of Camptothecin Prodrug

Hydroxycamptothecin-loaded Nanoparticles Enhance Target Drug Delivery and Anticancer Effect.

Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe3O4 nanoparticle-conjugated nanocarriers as an anti-colon cancer (HT29) drug

Enhanced Oral Bioavailability of 10-Hydroxycamptothecin Through the Use of Poly (N-Butyl Cyanoacrylate) Nanospheres.

Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice.

A Silica-Based Antioxidant Nanoparticle for Oral Delivery of Camptothecin Which Reduces Intestinal Side Effects While Improving Drug Efficacy for Colon Cancer Treatment.

Mixed Micelles Made of Pluronic/PEG-PE/TPGS for Solubilization of Camptothecin

In Vitro and in Vivo Anti-Tumor Efficacy of 10-Hydroxycamptothecin Polymorphic Nanoparticle Dispersions: Shape- and Polymorph-Dependent Cytotoxicity and Delivery of 10-Hydroxycamptothecin to Cancer Cells.

In Vitro and in Vivo Evaluation of 10-Hydroxycamptothecin-loaded Poly(n-Butyl Cyanoacrylate) Nanoparticles Prepared by Miniemulsion Polymerization

10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG 1000 -HCPT conjugate: high stabilizing efficiency and improved antitumor efficacy.

Chitosan surface-modified hydroxycamptothecin loaded nanoparticles with enhanced transport across Caco-2 cell monolayer.

Sustained Delivery of a Camptothecin Prodrug-Cz48 by Nanosuspensions with Improved Pharmacokinetics and Enhanced Anticancer Activity

Construction of l -Carnitine-Modified TPGS Micelles to Achieve Oral Delivery of Camptothecin and Targeted Anticancer Effects